Pfizer to buy two Baxter vaccines for $635 million

Reuters

Pfizer Inc (NYSE:PFE) agreed to buy two of Baxter International Inc's (NYSE:BAX) vaccines and a part of a facility involved in their production for $635 million.

Continue Reading Below

The deal will give Pfizer access to Baxter's NeisVac-C, a meningitis vaccine, and FSME-IMMUN, an encephalitis vaccine.

Both vaccines are already being sold in the United States.